Collegium Pharmaceutical, Inc. Common Stock

COLLNASDAQ • USD
25.21 USD
↘ 0.12 (0.45%)🟢LIVE (AS OF 12:52 PM EST)
🟢Market: OPEN

Collegium Pharmaceutical, Inc. Common Stock (COLL) is currently trading at $25.21. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest COLL is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$25.68
High?$25.79
Low?$25.06
Prev. Close?$25.32
Volume?125.0K
Avg. Volume?665.2K
VWAP?$25.25
Rel. Volume?0.19x
Bid / Ask
Bid?$25.14 × 100
Ask?$26.18 × 100
Spread?$1.04
Midpoint?$25.66
Valuation & Ratios
Market Cap?786.8M
Shares Out?31.1M
Float?30.6M
Float %?94.0%
P/E Ratio?20.62
P/B Ratio?2.65
EPS?$1.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Employees
423
Market Cap
786.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-05-07
Address
100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA 02072
Phone: 781-713-3699
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
8
Momentum?
35
Short Sent.?
45
Piotroski F-Score?3/9Weak
Altman Z-Score?0.80Distress
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.98%High
Short Interest?5.2M
Days to Cover?9.4
Free Float30.6M
Avg Daily Volume552.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.01Adequate
Quick Ratio?0.87Weak
Cash Ratio?0.24Low
Debt/Equity?3.65High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
63
20.6FAIR▾
P/B?
Peers
100
S&P
61
2.65CHEAP▾
P/S?
Peers
100
S&P
87
0.97CHEAP▾
P/FCF?
Peers
100
S&P
97
2.3CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
4.8CHEAP▾
EV/Sales?
Peers
100
S&P
73
2.11CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
47
12.9%STRONG▾
ROA?
Peers
50
S&P
18
1.8%WEAK▾
Cash Flow & Enterprise
FCF?$336.3M
Enterprise Value?$1.7B
Fundamentals ratios updated end of day